Licence No.: DIR 098
Licence holder: Sanofi-Aventis Australia Pty Ltd
Title: Commercial release of a genetically modified live viral vaccine to protect against Japanese encephalitis (IMOJEV™)
Issued: 19 August 2010
Transferred: 28 September 2010
Varied: 07 November 2012
More information about the decision to issue this licence is contained in the Risk Assessment and Risk Management Plan prepared in connection with the assessment of the application for the licence. This document can be obtained from the Office of the Gene Technology Regulator website, or by telephoning the Office on 1800 181 030.